# EDGAR Filing Document

**Accession Number:** 0001888047
**File Stem:** 0001104659-23-019065
**Filing Date:** 2023-2
**Character Count:** 72316
**Document Hash:** 28dc9526c76b12e5d8cce931681d9b17
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-019065.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001104659-23-019065

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**GROUP MEMBERS**: AFFAMED MANAGEMENT LTD

**GROUP MEMBERS**: AFFAMED THERAPEUTICS LTD

**GROUP MEMBERS**: C-BRIDGE CAPITAL GP IV, LTD.

**GROUP MEMBERS**: C-BRIDGE HEALTHCARE FUND GP IV, L.P.

**GROUP MEMBERS**: C-BRIDGE HEALTHCARE FUND IV, L.P.

**GROUP MEMBERS**: C-BRIDGE IV INVESTMENT SIX LTD

**GROUP MEMBERS**: C-BRIDGE IV INVESTMENT THREE GROUP LTD

**GROUP MEMBERS**: C-BRIDGE IV INVESTMENT TWENTY LTD

**GROUP MEMBERS**: C-BRIDGE JOINT VALUE CREATION LTD

**GROUP MEMBERS**: NOVA AQUA LTD

**GROUP MEMBERS**: TF CAPITAL IV, LTD.

**GROUP MEMBERS**: WEI FU

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GRAYBUG VISION, INC.
- **CENTRAL INDEX KEY:** 0001534133
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 452120079
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91725
- **FILM NUMBER:** 23614839

**BUSINESS ADDRESS:**
- **STREET 1:** 203 REDWOOD SHORES PARKWAY, SUITE 620
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
- **BUSINESS PHONE:** 650-487-2800

**MAIL ADDRESS:**
- **STREET 1:** 203 REDWOOD SHORES PARKWAY, SUITE 620
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG, Inc.
- **DATE OF NAME CHANGE:** 20150303

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG LLC
- **DATE OF NAME CHANGE:** 20111102
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AFFAMED PROJECT Ltd
- **CENTRAL INDEX KEY:** 0001888047
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** SUITE 3306-3307, TWO EXCHANGE SQUARE
- **STREET 2:** 8 CONNAUGHT PLACE, CENTRAL
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 86-21-5250-8618

**MAIL ADDRESS:**
- **STREET 1:** SUITE 3306-3307, TWO EXCHANGE SQUARE
- **STREET 2:** 8 CONNAUGHT PLACE, CENTRAL
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000

UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549

SCHEDULE 13G

**Under the Securities Exchange Act of 1934**

**(Amendment No. 2)<sup>\*</sup>**

**GRAYBUG VISION, INC.**

(Name of Issuer)

&nbsp;&nbsp;**Common Stock, par value $0.0001 per share**

(Title of Class of Securities)

**38942Q103**

(CUSIP Number)

&nbsp;&nbsp;**December 31, 2022**

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

◻ Rule 13d-1(b)

◻ Rule 13d-1(c)

⌧ Rule 13d-1(d)

<sup>\*</sup>The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, *see* the Notes).

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>2</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS | &nbsp;&nbsp;NAMES OF REPORTING PERSONS | &nbsp;&nbsp;NAMES OF REPORTING PERSONS |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**AffaMed Project Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**AffaMed Project Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**AffaMed Project Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;◻ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>3</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Therapeutics Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Therapeutics Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Therapeutics Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;◻ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>4</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Three Group Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Three Group Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Three Group Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin Islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>5</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Six Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Six Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Six Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;◻ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>6</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Twenty Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Twenty Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge IV Investment Twenty Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>7</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Management Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Management Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Affamed Management Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>8</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund IV, L.P.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund IV, L.P.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund IV, L.P.** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>9</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund GP IV, L.P.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund GP IV, L.P.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Healthcare Fund GP IV, L.P.** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**PN** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>10</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Capital GP IV, Ltd.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Capital GP IV, Ltd.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Capital GP IV, Ltd.** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>11</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Joint Value Creation Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Joint Value Creation Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C-Bridge Joint Value Creation Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>12</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TF Capital IV, Ltd.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TF Capital IV, Ltd.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TF Capital IV, Ltd.** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**cayman islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>13</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Nova Aqua Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Nova Aqua Limited** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Nova Aqua Limited** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**British Virgin islands** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CO** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>14</u> of <u>23</u> Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**1** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Wei fu** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Wei fu** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Wei fu** |
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | &nbsp;&nbsp;(a) □<br> (b) □ |
| &nbsp;&nbsp;**3** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** | &nbsp;&nbsp;**SEC USE ONLY** |
| &nbsp;&nbsp;**4** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**singapore** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**singapore** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**singapore** |
| &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**NUMBER OF** | &nbsp;&nbsp;**5** | &nbsp;&nbsp;SOLE VOTING POWER |
| &nbsp;&nbsp;**SHARES** | &nbsp;&nbsp;**SHARES** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**BENEFICIALLY** | &nbsp;&nbsp;**6** | &nbsp;&nbsp;SHARED VOTING POWER |
| **OWNED BY** | **OWNED BY** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**EACH** <br>**REPORTING** | &nbsp;&nbsp;**7** | &nbsp;&nbsp;SOLE DISPOSITIVE POWER |
| &nbsp;&nbsp;**PERSON** | &nbsp;&nbsp;**PERSON** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**WITH** | &nbsp;&nbsp;**8** | &nbsp;&nbsp;SHARED DISPOSITIVE POWER |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**9** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**-0-** |
| &nbsp;&nbsp;**10** | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | &nbsp;&nbsp;¨ |
| &nbsp;&nbsp;**11** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0%** |
| &nbsp;&nbsp;**12** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | &nbsp;&nbsp;TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IN** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IN** |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>15</u> of <u>23</u> Pages** |

---

Item 1.

&nbsp;&nbsp;&nbsp;&nbsp;(a) NAME
 OF ISSUER:

Graybug Vision, Inc.

&nbsp;&nbsp;&nbsp;&nbsp;(b) ADDRESS
 OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

203 Redwood Shores Parkway, Suite 620

Redwood City, CA 94065

Item 2.

&nbsp;&nbsp;&nbsp;&nbsp;(a) NAME
 OF PERSON FILING:

This Statement is being filed by and on behalf of AffaMed Project Limited, AffaMed Therapeutics Limited, C-Bridge IV Investment Three Group Limited, C-Bridge IV Investment Six Limited, C-Bridge IV Investment Twenty Limited, AffaMed Management Limited, C-Bridge Healthcare Fund IV, L.P., C-Bridge Healthcare Fund GP IV, L.P., C-Bridge Capital GP IV, Ltd., C-Bridge Joint Value Creation Limited, TF Capital IV, Ltd., Nova Aqua Limited and Mr. Wei Fu (collectively, the "Reporting Persons").

The shares reported herein are held directly by AffaMed Project Limited. AffaMed Project Limited is wholly owned by AffaMed Therapeutics Limited. AffaMed Therapeutics Limited is controlled by C-Bridge IV Investment Three Group Limited, C-Bridge IV Investment Six Limited, C-Bridge IV Investment Twenty Limited and AffaMed Management Limited. C-Bridge IV Investment Three Group Limited, C-Bridge IV Investment Six Limited, C-Bridge IV Investment Twenty Limited are each wholly owned by C-Bridge Healthcare Fund IV, L.P. C-Bridge Healthcare Fund GP IV, L.P. is the general partner of C-Bridge Healthcare Fund IV, L.P. C-Bridge Capital GP IV, Ltd. is the general partner of C-Bridge Healthcare Fund GP IV, L.P. C-Bridge Healthcare Fund GP IV, L.P. is controlled by TF Capital IV, Ltd. and Nova Aqua Limited. TF Capital IV, Ltd. is wholly owned by Nova Aqua Limited. AffaMed Management Limited is wholly owned by C-Bridge Joint Value Creation Limited. C-Bridge Joint Value Creation Limited is wholly owned by Nova Aqua Limited. Nova Aqua Limited is controlled by Mr. Wei Fu.

&nbsp;&nbsp;&nbsp;&nbsp;(b) ADDRESS
 OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

The business address of each of the Reporting Persons is Suite 3306-3307, Two Exchange Square, 8 Connaught Place, Central, Hong Kong.

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>16</u> of <u>23</u> Pages** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(c) CITIZENSHIP:

AffaMed Project Limited is a British Virgin Islands corporation. AffaMed Therapeutics Limited is a Cayman Islands corporation. C-Bridge IV Investment Three Group Limited is a British Virgin Islands corporation. C-Bridge IV Investment Six Limited is a British Virgin Islands corporation. C-Bridge IV Investment Twenty Limited is a British Virgin Islands corporation. AffaMed Management Limited is a British Virgin Islands corporation. C-Bridge Healthcare Fund IV, L.P. is a Cayman Islands limited partnership. C-Bridge Healthcare Fund GP IV, L.P. is a Cayman Islands limited partnership. C-Bridge Capital GP IV, Ltd. is a British Virgin Islands corporation. C-Bridge Joint Value Creation Limited is a British Virgin Islands corporation. TF Capital IV, Ltd. is a Cayman Islands corporation. Nova Aqua Limited is a British Virgin Islands corporation. Mr. Wei Fu is a citizen of Singapore.

&nbsp;&nbsp;&nbsp;&nbsp;(d) TITLE
 OF CLASS OF SECURITIES:

Common Stock, par value $0.0001 per share.

&nbsp;&nbsp;&nbsp;&nbsp;(e) CUSIP
 NUMBER: 38942Q103

Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§240.13d-1(b) or 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

---

| | |
|:---|:---|
| (a) ◻ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
| (b) ◻ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
| (c) ◻ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
| (d) ◻ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
| (e) ◻ | An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) ◻ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| (g) ◻ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |

---

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>17</u> of <u>23</u> Pages** |

---

---

| | |
|:---|:---|
| (h) ◻ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) ◻ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| (j) ◻ | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
| (k) ◻ | Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ |

---

Not applicable.

Item 4. OWNERSHIP:

The percentages set forth in this Item 4 are based on there being 21,562,523 shares of Common Stock outstanding as of November 7, 2022 as disclosed in Graybug Vision, Inc.'s Form 10-Q filed on November 10, 2022 for the quarterly period ended September 30, 2022.

<u>AffaMed Project Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>18</u> of <u>23</u> Pages** |

---

<u>AffaMed Therapeutics Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

<u>C-Bridge IV Investment Three Group Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

<u>C-Bridge IV Investment Six Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared power to dispose or to direct the disposition of: -0-

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>19</u> of <u>23</u> Pages** |

---

<u>C-Bridge IV Investment Twenty Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared power to dispose or to direct the disposition of: -0-

<u>AffaMed Management Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared power to dispose or to direct the disposition of: -0-

<u>C-Bridge Healthcare Fund IV, L.P.</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>20</u> of <u>23</u> Pages** |

---

<u>C-Bridge Healthcare Fund GP IV, L.P.</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

<u>C-Bridge Capital GP IV, Ltd.</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>21</u> of <u>23</u> Pages** |

---

<u>C-Bridge Joint Value Creation Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

<u>TF Capital IV, Ltd.</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>22</u> of <u>23</u> Pages** |

---

<u>Nova Aqua Limited</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT
 BENEFICIALLY OWNED (AS OF DECEMBER 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT
 OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER
 OF SHARES AS TO WHICH THE PERSON HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole
 power to vote or to direct the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared power to vote or to direct
 the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

<u>Wei Fu</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) AMOUNT BENEFICIALLY OWNED (AS OF DECEMBER
 31, 2022): -0-

&nbsp;&nbsp;&nbsp;&nbsp;(b) PERCENT OF CLASS: 0%

&nbsp;&nbsp;&nbsp;&nbsp;(c) NUMBER OF SHARES AS TO WHICH THE PERSON
 HAS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole power to vote or to direct the
 vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared power to vote or to direct
 the vote: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole
 power to dispose or to direct the disposition of: -0-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared
 power to dispose or to direct the disposition of: -0-

### Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ⌧

### Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
Not applicable.

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON:

Not applicable.

**SCHEDULE 13G**

---

| | | |
|:---|:---|:---|
| **CUSIP No.** | <u>38942Q103</u> | **Page <u>23</u> of <u>23</u> Pages** |

---

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

Not applicable.

Item 9. NOTICE OF DISSOLUTION OF GROUP:

Not applicable.

Item 10. CERTIFICATIONS:

Not applicable.

**<u>Signature</u>**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2023

---

| | | |
|:---|:---|:---|
| AFFAMED PROJECT LIMITED | AFFAMED PROJECT LIMITED | AFFAMED PROJECT LIMITED |
| By: | /s/ Hansoo Michael Keyoung | /s/ Hansoo Michael Keyoung |
|  | Name: | Hansoo Michael Keyoung |
|  | Title: | Director |
| AffaMed Therapeutics Limited | AffaMed Therapeutics Limited | AffaMed Therapeutics Limited |
| By: | /s/ Dayao ZHAO | /s/ Dayao ZHAO |
|  | Name: | Dayao ZHAO |
|  | Title: | Director |
| C-Bridge IV Investment Three Group Limited | C-Bridge IV Investment Three Group Limited | C-Bridge IV Investment Three Group Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| C-Bridge IV Investment Six Limited | C-Bridge IV Investment Six Limited | C-Bridge IV Investment Six Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |

---

---

| | | |
|:---|:---|:---|
| C-Bridge IV Investment Twenty Limited | C-Bridge IV Investment Twenty Limited | C-Bridge IV Investment Twenty Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| AffaMed Management Limited | AffaMed Management Limited | AffaMed Management Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| C-Bridge Healthcare Fund IV, L.P. | C-Bridge Healthcare Fund IV, L.P. | C-Bridge Healthcare Fund IV, L.P. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| C-Bridge Healthcare Fund GP IV, L.P. | C-Bridge Healthcare Fund GP IV, L.P. | C-Bridge Healthcare Fund GP IV, L.P. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| C-Bridge Capital GP IV, Ltd. | C-Bridge Capital GP IV, Ltd. | C-Bridge Capital GP IV, Ltd. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |

---

---

| | | |
|:---|:---|:---|
| C-Bridge Joint Value Creation Limited | C-Bridge Joint Value Creation Limited | C-Bridge Joint Value Creation Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| TF Capital IV, Ltd. | TF Capital IV, Ltd. | TF Capital IV, Ltd. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| Nova Aqua Limited | Nova Aqua Limited | Nova Aqua Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| /s/ Wei Fu | /s/ Wei Fu | /s/ Wei Fu |
| Wei Fu | Wei Fu | Wei Fu |

---

## Ex-99.A

**Exhibit 99.A**

**<u>Exhibit A</u>**

**<u>Joint Filing Agreement</u>**

The undersigned agree that the foregoing Statement on Schedule 13G (including any and all amendments thereto) is being filed with the Securities and Exchange Commission on behalf of each of the undersigned pursuant to Rule 13d-1(k) under the Act and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings.

Dated: February 13, 2023

---

| | | |
|:---|:---|:---|
| AFFAMED PROJECT LIMITED | AFFAMED PROJECT LIMITED | AFFAMED PROJECT LIMITED |
| By: | /s/ Hansoo Michael Keyoung | /s/ Hansoo Michael Keyoung |
|  | Name: | Hansoo Michael Keyoung |
|  | Title: | Director |
| AffaMed Therapeutics Limited | AffaMed Therapeutics Limited | AffaMed Therapeutics Limited |
| By: | /s/ Dayao ZHAO | /s/ Dayao ZHAO |
|  | Name: | Dayao ZHAO |
|  | Title: | Director |
| C-Bridge IV Investment Three Group Limited | C-Bridge IV Investment Three Group Limited | C-Bridge IV Investment Three Group Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| C-Bridge IV Investment Six Limited | C-Bridge IV Investment Six Limited | C-Bridge IV Investment Six Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |

---

---

| | | |
|:---|:---|:---|
| C-Bridge IV Investment Twenty Limited | C-Bridge IV Investment Twenty Limited | C-Bridge IV Investment Twenty Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| AffaMed Management Limited | AffaMed Management Limited | AffaMed Management Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| C-Bridge Healthcare Fund IV, L.P. | C-Bridge Healthcare Fund IV, L.P. | C-Bridge Healthcare Fund IV, L.P. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| C-Bridge Healthcare Fund GP IV, L.P. | C-Bridge Healthcare Fund GP IV, L.P. | C-Bridge Healthcare Fund GP IV, L.P. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| C-Bridge Capital GP IV, Ltd. | C-Bridge Capital GP IV, Ltd. | C-Bridge Capital GP IV, Ltd. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |

---

---

| | | |
|:---|:---|:---|
| C-Bridge Joint Value Creation Limited | C-Bridge Joint Value Creation Limited | C-Bridge Joint Value Creation Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| TF Capital IV, Ltd. | TF Capital IV, Ltd. | TF Capital IV, Ltd. |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Director |
| Nova Aqua Limited | Nova Aqua Limited | Nova Aqua Limited |
| By: | /s/ Wei Fu | /s/ Wei Fu |
|  | Name: | Wei Fu |
|  | Title: | Authorized Representative |
| /s/ Wei Fu | /s/ Wei Fu | /s/ Wei Fu |
| Wei Fu | Wei Fu | Wei Fu |

---